Arkolith/Insider Trading/BLTE/Form 4

Scholl Hendrik Peter

Chief Medical OfficerBELITE BIO, INC (BLTE) · full profile →Form 4 · filed Jun 22, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.5M
Net Open-Market Flow
-$1.5M
Transactions
5
5 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 18, 2026Sell(S)96$143.90$14K25K
Jun 18, 2026Sell(S)4K$144.66$542K21K
Jun 18, 2026Sell(S)5K$145.43$707K16K
Jun 18, 2026Sell(S)1K$146.24$175K15K
Jun 18, 2026Sell(S)96$147.11$14K15K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-276615) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML